Home › Funds › Vestal Point Capital, LP › QURE

Vestal Point Capital, LP position in QURE

UNIQURE NV · Health Care

Vestal Point Capital, LP reported holding 935,000 shares of QURE (UNIQURE NV) in its Q2 2026 13F filing — a position valued at US$43.1M, representing 1.01% of its reported portfolio and ranking #29 among its reported holdings. Vestal Point Capital, LP has disclosed QURE holdings in 10 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)935.00K sh
Reported value held$43.07M
Portfolio Weight1.01%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's QURE position evolved

Vestal Point Capital, LP first disclosed a stake in QURE in Q4 2023 at 3,925,000 shares (US$26.6M). The position peaked in Q4 2024 at 3,025,000 shares, worth US$53.4M. Across 10 filings, Vestal Point Capital, LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 935,000 shares valued at US$43.1M — an increase of 576,004 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2025 (shares rose 32% over the following quarter), a 94% trim in Q3 2025 (shares fell 59% over the following quarter), a 160% increase in Q2 2026 (shares fell 48% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 3.92M $26.57M New
Q1 2024 4.72M $24.57M Add
Q2 2024 4.75M $21.28M Add
Q3 2024 4.75M $23.42M Hold
Q4 2024 3.02M $53.42M Reduce
Q1 2025 4.79M $50.80M Add
Q2 2025 3.70M $51.58M Reduce
Q3 2025 225.00K $13.13M Reduce
Q1 2026 359.00K $5.87M New
Q2 2026 935.00K $43.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QURE and 13F data

QURE (UNIQURE NV) is a Health Care company. 64 other funds we track also report a position in QURE — the largest reported positions include Avoro Capital Advisors LLC (US$309.9M), RTW INVESTMENTS, LP (US$181.5M), ORBIMED ADVISORS LLC (US$83.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QURE

All QURE fund holders →

FAQ

How long has Vestal Point Capital, LP held QURE?

Vestal Point Capital, LP has disclosed QURE holdings in 10 of the last 11 reported quarters, going back to Q4 2023.

What is Vestal Point Capital, LP's current position in QURE?

As of Q2 2026, Vestal Point Capital, LP holds 935.00K shares of QURE (UNIQURE NV), valued at $43.07M, representing 1.01% of its reported portfolio and ranking #29.

Has Vestal Point Capital, LP been buying or selling QURE?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in QURE. The position peaked in Q4 2024 at 3.02M shares.

Which other funds hold QURE?

Other major institutional holders of QURE include Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.